In the BioHarmony Drug Report Database
Tenofovir disoproxil
Viread (tenofovir disoproxil) is a small molecule pharmaceutical. Tenofovir disoproxil was first approved as Viread on 2001-10-26. It is used to treat chronic hepatitis b and HIV in the USA. It has been approved in Europe to treat chronic hepatitis b and HIV infections.
Trade Name
|
Viread |
|---|---|
Common Name
|
tenofovir disoproxil |
ChEMBL ID
|
CHEMBL1538 |
Indication
|
chronic hepatitis b, hiv, hiv infections |
Drug Class
|
Antivirals |
Image (chem structure or protein)